{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-030435","form_type":"8-K","ticker":"ALBT","cik":"0001630212","company_name":"Avalon GloboCare Corp.","filed_at":"2025-04-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.125941+00:00","generated_at":"2026-05-23T17:16:59.846441+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"confidence":"high","headline":"Avalon GloboCare granted Chinese patent for CAR-T/NK cell technology; term 20 years","bullets":["Patent CN 114502188 B issued by CNIPA, effective April 4, 2025, with 20-year protection.","Co-developed with Hong Kong-based Arbele Limited; covers bispecific anti-CD19xCD22 CAR and localized cytokine induction.","Enhances expansion, manufacturing, survival, and efficacy of CAR-T and CAR-NK cells.","Adds to existing U.S. and PCT protections, strengthening global IP portfolio for cell-based immunotherapy."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-030435","json":"https://secwatch.observer/filing/0001213900-25-030435.json","markdown":"https://secwatch.observer/filing/0001213900-25-030435.md","text":"https://secwatch.observer/filing/0001213900-25-030435.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025030435/0001213900-25-030435-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630212/000121390025030435/ea0237706-8k_avalon.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T17:16:59.846441+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}